Désirée Gavhed

I currently share my worktime (50%) between and studies of CNS-LCH (pathology, treatment and late effects) in the Histiocytosis Research Team (40%) at the Division of Pediatric Oncology and Surgery, KI, and administration of the LCH-IV international treatment study protocol of LCH at the Pediatric oncology unit, Astrid Lindgren Children's hospital, Karolinska University Hospital Solna.

Activity areas
CNS in Langerhans cell histiocytosis (research), Treatment study protocol of Langerhans cell histiocytosis in children LCH-IV, European LCH-CNS registry; Rare Diseases (policy and research); Member of The Histiocyte Society, ICORD (International Conferences of Rare Diseases and Orphan drugs) and NOPHO (Nordic Society of Pediatric Hematology and Oncology).

Education: MSc Biology with specialization in Biomedicine and Physiology, Stockholm University; PhD in Medical Science (Physiology) at KI

Neurology, inflammation and late effects in CNS-LCH (Langerhans cell histiocytosis), diagnosis, monitoring, treatment of pediatric LCH

Administrator of Specialist Medical courses in Pediatric Hematology and
Oncology and PhD Research Course in Pediatric Hematology and Oncology since 2008.
Co-supervisor of PhD students at KI and Umeå University.
Supervised students at the Medical Programme at KI, Master students in
Biomedicine and Occupational Hygiene, and teached Applied Physiology at
University Programmes of Sports Exercise and Occupational Hygiene.